Waverly Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.83M Sell
32,456
-2,332
-7% -$500K 0.04% 369
2026
Q1
$7.69M Sell
34,788
-1,873
-5% -$458K 0.06% 312
2025
Q4
$9.29M Buy
36,661
+8,809
+32% +$2.21M 0.08% 257
2025
Q3
$6.89M Buy
27,852
+2,382
+9% +$570K 0.07% 267
2025
Q2
$6.12M Buy
25,470
+1,841
+8% +$429K 0.07% 269
2025
Q1
$5.36M Buy
23,629
+21,607
+1,069% +$4.75M 0.07% 285
2024
Q4
$416K Buy
+2,022
New +$444K 0.01% 728

Other funds holding STE

Waverly Advisors's STE Position: Q2 2026 in Review

Waverly Advisors reduced its Steris (STE) stake by 6.7% in Q2 2026, selling an estimated $500K and leaving 32,456 shares worth $6.83M. The position accounts for 0.04% of the portfolio, ranked #369.

Waverly Advisors first reported a position in STE in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.29M in Q4 2025. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Waverly Advisors held 32,456 shares of Steris worth $6.83M as of Q2 2026.
  • Waverly Advisors sold 2,332 Steris shares in Q2 2026, an estimated $500K.
  • Steris made up 0.04% of Waverly Advisors's portfolio in Q2 2026, its #369 holding.
  • Waverly Advisors first reported a position in Steris in Q4 2024 and has held it in 7 quarters since.
  • Waverly Advisors's Steris position peaked at $9.29M in Q4 2025.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.